Research ArticleTUMOR IMMUNOLOGY

IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer

See allHide authors and affiliations

Science Immunology  17 Apr 2020:
Vol. 5, Issue 46, eaav3942
DOI: 10.1126/sciimmunol.aav3942

Article Information

vol. 5 no. 46

PubMed: 
Published By: 
History: 
  • Received September 12, 2018
  • Revision received November 2, 2019
  • Accepted March 26, 2020
  • .

Author Information

  1. Margaux Hubert1,2,
  2. Elisa Gobbini1,3,
  3. Coline Couillault1,
  4. Thien-Phong Vu Manh4,
  5. Anne-Claire Doffin1,
  6. Justine Berthet1,2,
  7. Céline Rodriguez1,2,
  8. Vincent Ollion1,5,
  9. Janice Kielbassa6,
  10. Christophe Sajous1,
  11. Isabelle Treilleux7,
  12. Olivier Tredan7,
  13. Bertrand Dubois1,2,
  14. Marc Dalod4,
  15. Nathalie Bendriss-Vermare1,2,5,
  16. Christophe Caux1,2,5,7,* and
  17. Jenny Valladeau-Guilemond1,5,*,
  1. 1Univ Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, 69008, France.
  2. 2Laboratoire d’Immunothérapie des Cancers de Lyon (LICL), Lyon, France.
  3. 3CHU Grenoble-Alpes, France.
  4. 4Aix Marseille Univ, CNRS, INSERM, Centre d’Immunologie de Marseille-Luminy, Marseille, France.
  5. 5LabEx DEVweCAN, Lyon, France.
  6. 6Synergie Lyon Cancer, Plateforme de Bio-informatique ‘Gilles Thomas’, Lyon, France.
  7. 7Centre Léon Bérard, F-69008 Lyon, France.
  1. Corresponding author. Email: jenny.valladeau{at}lyon.unicancer.fr
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: April 2020 to October 2020

AbstractFullPdf
Apr 2020500123382291
May 20201218332176
Jun 20202678152
Jul 20202644440
Aug 20201812621
Sep 20201404624
Oct 20201021514

Stay Connected to Science Immunology